Remove controlling-diabetes-advances-adherence
article thumbnail

Controlling Diabetes: Advances & Adherence

Pharmaceutical Commerce

Proper control of type 1 and 2 diabetes can greatly reduce the personal impact and economic burden of this pervasive public health condition. To that end, stakeholders are exploring many parallel routes to help individuals and society maintain the upper hand, as the toll of diabetes continues to skyrocket.

106
106
article thumbnail

In conversation with consultant pharmacist in cardiology Dr Rani Khatib

Hospital Pharmacy Europe

Optimising medicines and adherence post-MI Having noted suboptimal secondary prevention medicine (SPM) regimes and low adherence among myocardial infarction (MI) patients , Dr Khatib embarked on a project to ‘re-engineer’ post-MI care. The completed questionnaire is a starting point for Dr Khatib to dig deeper. ‘It

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can probiotics help treat diabetes?

The Checkup by Singlecare

Patients with diabetes, in particular, may be curious about whether they can take probiotics and how probiotics may affect their blood sugar levels. As it turns out, research has shown several potential benefits of probiotics for diabetes. The main genera of bacteria studied were Lactobacillus and Bifidobacterium.

Dosage 92
article thumbnail

Five for Friday October 6: Celebrating Success in Advancing Medication Use Quality

PQA

also highlight our members' perspectives on medication adherence in rheumatoid arthritis, adherence in vulnerable populations, and baseline health screenings. In addition, the findings support the PDC-RA methodology presented about calculated adherence rates used for reporting requirements." Learn more about the program below.We

article thumbnail

Enhancing collaboration to optimise medication therapy in older adults with cancer: a position paper from SOFOG-SFPO

Hospital Pharmacy Europe

They are particularly vulnerable to drug-related problems (DRPs), such as medication errors and inappropriate medication use, adverse drug effects, drug–drug interactions (DDIs), or difficulties with adherence. As these patients are often treated with multiple medications, the benefit–risk ratios should be regularly reassessed.

article thumbnail

Bad behaviour: why understanding human behaviour can improve outcomes

pharmaphorum

Human behaviour underpins our actions towards medication adherence, physical activity, tobacco and drug use. Advances in digital tools and medical devices have also enabled better outcomes through better decisions. More systematic approaches to understanding behaviour and the interventions that support change appear in the literature.

article thumbnail

New Medication has Implications to avoid Would-be Chronic Diseases

PharmD Live

1 Obesity increases the risk for many health problems, such as type 2 diabetes, high blood pressure, heart disease, stroke, joint disorders, liver disease, gallstones, some types of cancer, and sleep apnea among other conditions. All patients with diabetes were excluded from the study. This number has increased dramatically from 30.5%